Therefore, the key questions that need to be explored are connected with the possibility of using VIP as a regulatory factor in the functioning of the carotid body to maintain cardiorespiratory homeostasis and to potentially remedy hypertension, systolic heart failure and other disorders in which chemoreceptor activity plays an important role. This evidence concerns the gene VIP and systolic heart failure.